News Search

Author: Samantha Savello

Dispatch Bio Developing Tumor-Agnostic Immunotherapy Targeting Solid Tumors  

The technology, now in preclinical development, has the potential to overcome the limitations of traditional cancer treatments for solid tumors.

Opus Genetics Reports Positive Pediatric Data from its Clinical Trial Evaluating Investigational Gene Therapy for a Rare Eye Disorder  

These findings suggest OPGx-LCA5, Opus Genetics' investigational gene augmentation therapy, could improve vision for patients previously considered untreatable.

GEMMA Biotherapeutic Announces Clinical Trial Authorization for New Gene Therapy Treatment 

Its novel gene therapy for spinal muscular atrophy type 1 (SMA1) has been cleared for clinical trial in Brazil by ANVISA.

Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel 

Rese-cel is an experimental CAR T-cell therapy designed to “reset” the immune system in people with autoimmune diseases.

Sonura’s Novel NICU Technology Featured in the Philadelphia Inquirer    

Now being tested in a clinical trial at Penn, the device aims to reduce infant stress, support bonding, and potentially improve growth and feeding for preterm babies.

Avisi Technologies Announces First Patient Implanted with Glaucoma Treatment Device in Clinical Trial 

Avisi treated its first patient in a clinical trial to evaluate the safety and effectiveness of its novel VisiPlate® glaucoma treatment device.

BlueWhale Bio Raises $5M, Partners with Avantor, Inc. 

BlueWhale Bio was co-founded by Carl June, MD, the Richard W. Vague Professor in Immunotherapy and James Riley, PhD, Professor of Microbiology, both at Penn Medicine.

PCI Hosts 10th Annual Celebration of Innovation  

On December 2, PCI celebrated Penn researchers and innovators named as inventors on patents issued to Penn this past fiscal year.

University of Pennsylvania Launches StartUP Fund 

Penn announced the launch of its StartUP Fund.

Vital Start Health Expands Virtual Mental Health Platform

Vital Start Health is co-founded by John Chuo, MD, MSBI, Chief Scientific Officer, Professor of Clinical Pediatrics at Penn Medicine, and Neonatal Quality Officer at CHOP.

Filter

Skip to content